Please ensure Javascript is enabled for purposes of website accessibility

Why Sundial Growers Stock Popped Wednesday Morning

By Howard Smith – Aug 18, 2021 at 11:24AM

Key Points

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An investment just announced in the cannabis industry has investors looking at Sundial's acquisitive strategy.

What happened

Shares of Canadian marijuana grower Sundial Growers (SNDL 6.27%) popped early Wednesday with a jump of almost 6%. The stock didn't hold those gains, but remained up about 1.5% as of 10:30 a.m. EDT today. 

So what

Initial investor interest today likely came after another Canadian cannabis company announced a new investment in the U.S. market. Tilray (TLRY 7.75%) said last night that it has acquired the majority of the outstanding senior secured convertible notes of U.S.-based cannabis retailer MedMen Enterprises (MMNFF 1.33%). This puts Tilray in a position to potentially own a significant equity stake in MedMen, which would give it a path to the U.S. cannabis market should federal legalization materialize. So why did Sundial investors react to this? Because Sundial has made acquisitions a key portion of its future strategy, and Tilray's move could be a framework for Sundial, too. 

marijuana leaves on US flag sign.

Image source: Getty Images.

Now what

Sundial restructured its business last year, raising significant capital in the process. This heavily diluted shareholders, who are now counting on the company to smartly put that money to work. In addition to streamlining its cannabis operations, Sundial created an investment pillar to its business, which will seek acquisition targets. There are many risks to successfully managing this strategy, but Tilray's move gives other Canadian marijuana companies a potential path to follow. 

Tilray's investment in a U.S. multi-state retailer gives it a potential avenue into the U.S. should federal legalization occur. And Tilray CEO Irwin Simon made it clear he believes that day is coming. Simon stated the new investment "is a critical step toward delivering on our objective as we work to enable Tilray to lead the U.S. market when legalization allows."

With Sundial having about $1 billion on its balance sheet and no debt as of Aug. 9, its investors are counting on that business pillar to move the company to profitability. 

Howard Smith owns shares of Tilray, Inc. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stocks Mentioned

Sndl  Stock Quote
$2.88 (6.27%) $0.17
MedMen Enterprises Inc. Stock Quote
MedMen Enterprises Inc.
$0.03 (1.33%) $0.00
Tilray Brands Stock Quote
Tilray Brands
$4.17 (7.75%) $0.30

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.